The largest database of trusted experimental protocols

Analyst ad

Manufactured by Molecular Devices
Sourced in United States

The Analyst AD is a high-performance microplate reader designed for researchers in life science and drug discovery applications. It provides precise and accurate absorbance measurements across a wide range of wavelengths, enabling a variety of assay types to be performed. The core function of the Analyst AD is to quantify and analyze samples in a microplate format.

Automatically generated - may contain errors

8 protocols using analyst ad

1

In Vitro Amyloid Fibril Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples of each filtered and ultracentrifuged protein were prepared, on ice, at a final concentration of 20 µM in 10 mM ABC buffer (pH 2.0) containing 150 mM NaCl, 10 µM thioflavin T (ThT), and 0.02% NaN3, in 1.5 mL low-binding microcentrifuge tubes (total volume of 1.0 mL).
In vitro fibrillogenesis reactions were conducted by monitoring the fluorescence emission enhancement of thioflavin T (ThT) that occurs when ThT binds to amyloid fibrils. All fibril formation assays were performed in triplicate (260 µL per well) using black 96-well polystyrene plates (Greiner, Monroe, NC) sealed with plate sealers (Nunc, Roskilde, Denmark), covered with a black polystyrene cover, and sealed with tape to reduce evaporation. Samples were incubated at 37 °C while being continuously orbitally shaken (300 rpm) in a New Brunswick Scientific Innova40 incubator shaker. Fibril formation was monitored daily for 1 month (~750 h) following fluorescence on a plate reader (Analyst AD, Molecular Devices, Sunnyvale, CA). The excitation wavelength used was 440 nm, and the emission wavelength was 480 nm. The plate sealer and the tape sealing the cover were replaced daily.
We considered that a fibril formation reaction had occurred when we observed an at least 4-fold ThT fluorescence enhancement (~200000 AU in our system). The presence of amyloid fibrils was confirmed by electron microscopy.
+ Open protocol
+ Expand
2

Screening Hepatocyte Carcinoma Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human Caucasian hepatocyte carcinoma cells (HepG2; European Collection of Cell Cultures, Salisbury, United Kingdom) were grown in accordance with their guidelines by using DMEM. Cells at a density of 30,000 cells/well in 96-well plates were incubated overnight (37°C, 5% CO2 atmosphere). Medium was then removed and replaced with DMEM that contained control or compounds (1, 10, and 100 μM; n = 2 per concentration) for 24 h before addition of 100 μl/well of CellTiter-Glo Reagent (Promega, Madison, WI, USA) for ATP measurement and shaken to induce cell lysis. Luminescence was quantified on an AnalystAD plate-reader (Molecular Devices, Sunnyvale, CA, USA). Thioridizine (known HepG2 cytotoxicity) was used as positive control. Study was carried out by BioFocus DPI (Saffron Walden, United Kingdom).
+ Open protocol
+ Expand
3

Determining Drug-Induced Cell Proliferation Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of the drug on cell proliferation was determined using a CellTiter-Glo Luminescent Cell Viability Assay kit (Promega, Madison, WI), which is based on quantification of the cellular ATP level. Cells were plated in 96-well plates at a density of 2,000–5,000 cells (8 replicates per condition). The following day, cells were treated with a range of drug concentrations prepared by serial dilution. After 3–5 days of treatment, 100 ml of prepared reagent was added to each well. The contents of the wells were mixed on a plate shaker for 1 hour, and then luminescence was measured by an Analyst AD (Molecular Devices, Sunnyvale, CA). The relative growth was normalized to the untreated samples in each group. The growth or inhibition curves and IC50 values were calculated with Graph Pad Prism v.6.
+ Open protocol
+ Expand
4

Monitoring Amyloid Fibril Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
ThT fluorescence from the aggregation mixture was monitored on a plate reader (Analyst AD; Molecular Devices, Sunnyvale, CA). An aliquot (~260 μL) of the fibril formation reaction (containing ThT) was placed in duplicate on a black 96 well polystyrene plate (Greiner, Monroe, NC) at specific time points (equivalent to the time points used for the sedimentation assay) to measure the fluorescence intensity. After the measurements, we placed back the reaction mixture into the microcentrifuge tube and resumed incubation at 37°C, 300 RPM in the orbital shaker till the end of the aggregation reaction. We repeat this process periodically to obtain the ThT intensity for all the time points presented in the figures. All the fluorescence measurements were done using an excitation wavelength of 440 nm and an emission wavelength of 480 nm.
For both the sedimentation and the Thioflavin T assay, we assumed the aggregation reaction had ended when the change in the minimum concentration of monomers or the Thioflavin T fluorescence intensity maximum remained constant over a period of at least 48 hrs.
+ Open protocol
+ Expand
5

Monitoring Amyloid Aggregation Kinetics

Check if the same lab product or an alternative is used in the 5 most similar protocols
ThT fluorescence from the aggregation mixture was monitored on a plate reader (Analyst AD; Molecular Devices, Sunnyvale, CA) using an excitation wavelength of 440 nm and an emission wavelength of 480 nm as previously reported [21 (link)]. Two aliquots (~260 μL technical replicates) from the aggregation reaction (containing 20 μM ThT) were placed on a black 96-well polystyrene plate (Greiner, Monroe, NC) at specific time points to measure the fluorescence intensity. After the measurements, aliquots were placed back into the microcentrifuge tube to resume the incubation at 37°C with orbital shaking set at 300 RPM. The measurement process was repeated until the apparent change in fluorescence intensity plateaus over a period of at least 72 h.
+ Open protocol
+ Expand
6

Determining Drug-Induced Cell Proliferation Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of the drug on cell proliferation was determined using a CellTiter-Glo Luminescent Cell Viability Assay kit (Promega, Madison, WI), which is based on quantification of the cellular ATP level. Cells were plated in 96-well plates at a density of 2,000–5,000 cells (8 replicates per condition). The following day, cells were treated with a range of drug concentrations prepared by serial dilution. After 3–5 days of treatment, 100 ml of prepared reagent was added to each well. The contents of the wells were mixed on a plate shaker for 1 hour, and then luminescence was measured by an Analyst AD (Molecular Devices, Sunnyvale, CA). The relative growth was normalized to the untreated samples in each group. The growth or inhibition curves and IC50 values were calculated with Graph Pad Prism v.6.
+ Open protocol
+ Expand
7

Fluorescence Polarization Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fluorescence polarization measurements were taken using an Analyst AD (Molecular Devices) with 530 nm excitation and 580 nm emission filters and 561 nm dichroic mirror. All experiments were conducted at room temperature in duplicate and used PBS supplemented with 0.5 mg/ml bovine gamma-globulin (Sigma) and 0.5 mM dithiothreitol, in a volume of 60 μl. Binding of TAMRA-labelled peptide is reported in millipolarisation units (mP) and is obtained from the equation, mP = 1000 × (S - G × P)/(S + G × P), where S and P are background-subtracted fluorescence count rates (S = polarised emission filter is parallel to the excitation filter; P = polarised emission filter is perpendicular to the excitation filter), and G (grating) is an instrument- and assay-dependent factor.
+ Open protocol
+ Expand
8

SH2 Domain Binding Affinity Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
SH2 domains were dialyzed into binding buffer (50 mM HEPES, pH 7.25, 150 mM NaCl, 0.01% NP40, 5% glycerol) and 30 µl volume serially diluted into prechilled 384-well low-flange black, flat-bottom nonbinding microplate (Corning) while on ice. A 5-µl amount of 35 nM fluorescent peptide dissolved in binding buffer was added to each well (final concentration 5 nM) and mixed five times by pipetting, and plates were incubated at 4°C for 40 min. Fluorescence polarization experiments were performed with an Analyst AD (Molecular Devices, Sunnyvale, CA) spectrofluorimeter. Each well was excited using 485-nm light, and emission was read at 530 nm. Fluorescence polarization was measured 1 mm from the bottom of each well with an integration time of 560 ms. All experiments were conducted in triplicate. The change in fluorescence polarization was normalized such that maximum change for each condition was set at an arbitrary value of 100 for the ease of comparison. Normalized values were graphed and fit to a single-binding-site hyperbola using GraphPad Prism.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!